Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Dyslipidemia Clinical Trials

A listing of Dyslipidemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (4) clinical trials

Effect of Administration of the Combination Bezafibrate More Berberine on Lipid Profile in Patients With Dyslipidemia

Clinical trial, double-blind, simple random assignment and parallel groups. Three study groups of patients will be between 30-60 years of age diagnosed with mixed dyslipidemia with failure to control medical nutrition therapy, which by simple random assignment with random numbers will be assigned to one of three groups: 1. 20 ...

Phase

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects with Severe Hypertriglyceridemia (INDIGO-1)

Phase

Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women.

The prevalence of metabolic disorders including dyslipidemia increases as women transition from premenopause to postmenopause. This increases the risk for morbidity and mortality from cardiovascular diseases. Carduus marianus is a homeopathic medicine that traditionally has been used for hepatic diseases. Silymarin, isolated from Carduus marianus, owe its therapeutic and hepatoprotective ...

Phase

Evaluate the Safety and Efficacy of Saroglitazar Magnesium in Patients With Fasting Triglyceride 500 mg/dL and 1500 mg/dL

SARO.15.001.04 is a multicenter, prospective, randomized, double-blind, placebo-controlled, parallel arm, 12-week study designed to evaluate the safety and efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in patients with fasting triglyceride 500 mg/dL and 1500 mg/dL. A total 124 subjects will be enrolled in a ratio of 1:1:1:1 to ...

Phase